Lipigon Pharmaceuticals AB (publ) (STO:LPGO)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.0015
-0.0012 (-44.44%)
Inactive · Last trade price on May 18, 2026

STO:LPGO Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
--10.2916.41-2.21
Revenue Growth
---37.30%---44.86%
Gross Profit
-22.84-22.84-18.41-5.12-31.66-36.04
Operating Income
-32.29-32.29-26.93-13.45-38.13-42.16
Net Income
-32.44-32.44-25.26-12.13-37.71-41.11
Earnings Per Share
-0.08-0.08-0.18-0.19-2.57-4.56
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash (Debt)
10.2110.2111.7831.939.6428.47
Net Cash Growth
-13.26%-13.26%-63.12%231.30%-66.15%126.81%
Net Cash Per Share
0.030.030.090.500.663.16
Cash & Investments
10.2110.2111.7831.939.6428.47

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-35.77-35.77-24.78-14.32-37.47-35.3
Capital Expenditures
-0.11-0.11-0.24---0.12
Free Cash Flow
-35.88-35.88-25.02-14.32-37.47-35.42
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
---179.00%-31.19%--
Operating Margin
---261.74%-81.95%--1906.83%
Pretax Margin
---245.59%-73.92%--1859.48%
Profit Margin
---245.59%-73.92%--1859.48%
FCF Margin
---243.18%-87.27%--1601.94%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
--1.663.32-28.61